Companies / BOC Sciences / Pozelimab
BOC Sciences

Pozelimab | BOC Sciences

Pozelimab is a human IgG4 monoclonal antibody directed against complement C5. Pozelimab has been used in the research of CHAPLE disease, also known as CD55-deficient protein-losing enteropathy.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.